NetworkNewsBreaks

ThursdayDec 05, 2019 11:02 am

NetworkNewsBreaks – No Borders Inc. (NBDR) Announces Qualification of $3M Reg A Offering in New York and Colorado

No Borders (OTC: NBDR) today announced “qualification” of its Reg A offering with the states of New York and Colorado to offer its up to $3 million capital raise to investors in these states. Per the update, NBDR continues to work with and file for qualification in several additional states and, as those processes move forward, will continue to expand its networking and engagement operations to ensure the highest market visibility and best strategic capital position for the organization. “I am so happy to have the opportunity to offer investors in the great states of Colorado and New York an…

Continue Reading

ThursdayDec 05, 2019 10:30 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Provides Update on Infrastructure that Serves Dedicated Functions from Seed to Sale

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today provided an operational update on its focused infrastructure that serves dedicated functions from seed to sale. Per the update, the company leased its manufacturing, processing and packaging facility located in Kitchener, Ontario (“Supreme Cannabis Kitchener”) in response to internal requirements and foreseeable market demand. Supreme Cannabis Kitchener will function as a central manufacturing, processing and packaging facility for Supreme Cannabis brands and, once complete, a location where the company intends to package, distribute and brand third-party cannabis inputs from quality-focused cultivators. “With Supreme Cannabis Kitchener, we add the infrastructure to…

Continue Reading

ThursdayDec 05, 2019 9:55 am

NetworkNewsBreaks – OriginClear, Inc. (OCLN) and Spain-Based Licensee Depuporc Unveil Comprehensive Manure Treatment System

OriginClear (OTC: OCLN), a leading provider of water treatment solutions, together with its Spain-based licensee Depuporc S.L. (www.Depuporc.com), today announced successful completion of a comprehensive system with the capabilities to continuously transform pig manure into a zero-waste output of fertilizer and clean irrigation water. According to the update, a leading Spanish pork producer hosted a demonstration version of the system as part of its plan to dramatically increase production while complying with strict European Union limits. A company video featuring the system is available on OCLN's website (http://nnw.fm/0lAkL). “Most operators in the region are planning large increases in hog farming,…

Continue Reading

ThursdayDec 05, 2019 9:34 am

NetworkNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) Increases Non-Brokered Private Placement

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, today announced it has increased the size of its previously announced non-brokered private placement. On or about December 10, the company expects to close on a total of 10,490,886 units for gross proceeds of C$3,671,810. The private placement consists of units, which are each comprised of one common share and one-half of one common share purchase warrant, at a price of C$0.35 each. Each full warrant entitles the holder to acquire one common share at a price of C$0.50 for a…

Continue Reading

WednesdayDec 04, 2019 3:38 pm

NetworkNewsBreaks – OTC Markets Group Initiates Discussion Regarding SEC’s Recent Rule Proposal

OTC Markets Group has invited the investment community to engage in a discussion regarding the SEC’s recent rule proposal on the Publication or Submission of Quotations Without Specified Information, which governs the public quoting of securities on OTCQX, OTCQB and Pink markets. In response to the proposal, OTC Markets recently published preliminary comments including several recommendations to enhance the effectiveness of the rule in the event that the SEC decides to implement the proposed amendments. OTC Markets also published a webinar on understanding the impact of the SEC’s Rule 15c2-11 Proposal. Among other changes, the rule proposal would require that up-to-date…

Continue Reading

WednesdayDec 04, 2019 2:44 pm

NetworkNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Platform Revolutionizing Cancer Treatment

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven, precision-medicine company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. An article discussing the company reads, “POAI’s platform, composed of over 150,000 patient tumors, harnesses the power of an individual patient’s tumor to help recommend the best treatment for that patient. This database, which houses evidence documenting actual drug responses of cancer patients’ individual tumors, uses artificial intelligence to create a valuable predictive tool for pharmaceutical companies and researchers. . . . Industry leaders believe that models utilizing patient-derived data powered by artificial intelligence will allow doctors to make…

Continue Reading

WednesdayDec 04, 2019 2:38 pm

NetworkNewsBreaks – Wonderfilm Media Corp.’s (TSX.V: WNDR) (OTCQB: WDRFF) Low-Risk Content Production Approach Provides Consistent Revenue Stream

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, has developed a low risk production process that supports steady, predictable revenues. A recent article discussing the company reads, “Soaring demand for content from streaming providers is fueling industry growth with established media giants in an all-out sprint to dominate some very lucrative revenue streams, a Bloomberg article states (http://nnw.fm/Ch98D). One segment of this industry, the global video on demand market, was valued at $28.9 billion in 2017 and is expected to reach $89.3 billion by 2026 at a compound annual growth rate…

Continue Reading

WednesdayDec 04, 2019 1:46 pm

NetworkNewsBreaks – SiTime Corp. (NASDAQ: SITM) Secures $64.3 Million in Initial Public Offering

SiTime Corporation (NASDAQ: SITM), a market leader in MEMS timing, has closed its initial public offering of 4,945,000 shares of its common stock, including 645,000 additional shares per the full exercise of the over-allotment option. According to the update, SiTime secured approximately $64.3 million in gross proceeds, with each of the shares sold at the public offering price of $13.00. ROTH Capital Partners acted as a co-manager for the offering. To view the full press release, visit http://nnw.fm/kHa7f About SiTime SiTime Corporation, a market leader in MEMS timing and a wholly-owned subsidiary of MegaChips Corporation, offers MEMS-based silicon timing system…

Continue Reading

WednesdayDec 04, 2019 1:27 pm

NetworkNewsBreaks – Co-Diagnostics, Inc.’s (NASDAQ: CODX) JV CoSara Secures Clearance for Five Diagnostic Assays to be Manufactured, Sold as IVDs from India-Based Facility

Co-Diagnostics (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that its joint venture for manufacturing, CoSara Diagnostics Pvt Ltd, has obtained regulatory clearance for five tests to be manufactured and sold as in vitro diagnostics (“IVDs”) from its Ranoli, India-based facility. According to the update, the Saragene(TM) tests for Mycobacterium tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (“HPV”) meet requirements of the Central Drug Standard Control Organization Medical Device Rules 2017, File no. 29/Misc./3/2017-DC (292), to be manufactured and sold as IVDs. “India is soon to…

Continue Reading

WednesdayDec 04, 2019 1:02 pm

NetworkNewsBreaks – Soligenix, Inc. (NASDAQ: SNGX) Completes Enrollment in Pivotal Phase 3 SGX301 Clinical Trial in Treatment of Cutaneous T-cell Lymphoma

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today completion of patient enrollment in its Phase 3 "Fluorescent Light Activated Synthetic Hypericin" (“FLASH”) study for SGX301 (“synthetic hypericin”) in the treatment of cutaneous T-cell lymphoma (“CTCL”). According to the update, 169 subjects were successfully enrolled in the study following positive interim analysis, which included a prospectively defined, unblinded assessment of the study's primary efficacy endpoint by an independent Data Monitoring Committee (“DMC”). “We are pleased to have completed enrollment and look forward to…

Continue Reading